Proteasomal degradation unleashes the pro-death activity of androgen receptor

Cell Research

Volumn 20, Issue 10, 2010, Pages 1138-1147

  Godfrey, Bradley ^a   Lin, Yuting ^a   Larson, Jeffery ^a   Haferkamp, Bonnie ^a   Xiang, Jialing ^a  

^a Illinois Institute of Technology   (United States)

Author keywords

Androgen receptor; apoptosis; pro death domain; proteasomal degradation

Indexed keywords

ANDROGEN RECEPTOR; CASPASE; ENZYME INHIBITOR; PROTEASOME; PROTEIN BCL 2; SMALL INTERFERING RNA; STAUROSPORINE;

APOPTOSIS; ARTICLE; DRUG ANTAGONISM; GENETICS; HUMAN; METABOLISM; PHYSIOLOGICAL STRESS; PROTEIN TERTIARY STRUCTURE; RNA INTERFERENCE; TUMOR CELL LINE; ULTRAVIOLET RADIATION;

APOPTOSIS; CASPASES; CELL LINE, TUMOR; ENZYME INHIBITORS; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ANDROGEN; RNA INTERFERENCE; RNA, SMALL INTERFERING; STAUROSPORINE; STRESS, PHYSIOLOGICAL; ULTRAVIOLET RAYS;

EID: 77957590904     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2010.65     Document Type: Article

References (34)

1. Kokontis JM, Hsu S, Chuu CP, et al. Role of androgen receptor in the progression of human prostate tumor cells to andro-gen independence and insensitivity. Prostate 2005; 65:287-298.
2. Chang C, Kokontis J, Swift S, et al. Molecular cloning and structural analysis of complementary DNA of human and rat androgen receptors. Prog Clin Biol Res 1990; 322:53-63.
3. Chang CS, Kokontis J, Liao ST. Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc Natl Acad Sci USA 1988; 85:7211-7215.
4. Culig Z, Klocker H, Bartsch G, et al. Androgen receptors in prostate cancer. J Urol 2003; 170:1363-1369.
5. Chatterjee B. The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer. Mol Cell Biochem 2003; 253:89-101.
6. Georget V, Lobaccaro JM, Terouanne B, et al. Traffcking of the androgen receptor in living cells with fused green fuores-cent protein-androgen receptor. Mol Cell Endocrinol 1997; 129:17-26.
7. Tomura A, Goto K, Morinaga H, et al. The subnuclear three-dimensional image analysis of androgen receptor fused to green fluorescence protein. J Biol Chem 2001; 276:28395-28401.
8. Liao SS, Kokontis J, Sai T, et al. Androgen receptors: structures, mutations, antibodies and cellular dynamics. J Steroid Biochem 1989; 34:41-51.
9. Chamberlain NL, Whitacre DC, Miesfeld RL. Delineation of two distinct type 1 activation functions in the androgen receptor amino-terminal domain. J Biol Chem 1996; 271:26772-26778.
10. Lavery DN, McEwan IJ. Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations. Biochem J 2005; 391:449-464.
11. Zhou ZX, Kemppainen JA, Wilson EM. Identifcation of three proline-directed phosphorylation sites in the human androgen receptor. Mol Endocrinol 1995; 9:605-615.
12. Nazareth LV, Weigel NL. Activation of the human androgen receptor through a protein kinase A signaling pathway. J Biol Chem 1996; 271:19900-19907.
13. Gioeli D, Ficarro SB, Kwiek JJ, et al. Androgen receptor phosphorylation. Regulation and identification of the phos-phorylation sites. J Biol Chem 2002; 277:29304-29314.
14. Beitel LK, Elhaji YA, Lumbroso R, et al. Cloning and characterization of an androgen receptor N-terminal-interacting protein with ubiquitin-protein ligase activity. J Mol Endocrinol 2002; 29:41-60.
15. Poukka H, Karvonen U, Janne OA, et al. Covalent modifca-tion of the androgen receptor by small ubiquitin-like modifer 1 (SUMO-1). Proc Natl Acad Sci USA 2000; 97:14145-14150.
16. Claessens F, Denayer S, Van Tilborgh N, et al. Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nucl Recept Signal 2008; 6:e008.
17. Risek B, Bilski P, Rice AB, et al. Androgen receptor-mediated apoptosis is regulated by photoactivatable androgen receptor ligands. Mol Endocrinol 2008; 22:2099-2115.
18. Isaacs JT. Apoptosis: translating theory to therapy for prostate cancer. J Natl Cancer Inst 2000; 92:1367-1369.
19. Heisler LE, Evangelou A, Lew AM, et al. Androgen-depen-dent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor. Mol Cell Endocrinol 1997; 126:59-73.
20. Young JE, Garden GA, Martinez RA, et al. Polyglutamine-expanded androgen receptor truncation fragments activate a Bax-dependent apoptotic cascade mediated by DP5/Hrk. J Neurosci 2009; 29:1987-1997.
21. Yeh S, Hu YC, Rahman M, et al. Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells. Proc Natl Acad Sci USA 2000; 97:11256-11261.
22. Lin Y, Kokontis J, Tang F, et al. Androgen and its receptor promote bax-mediated apoptosis. Mol Cell Biol 2006; 26:1908-1916.
23. Palazzolo I, Gliozzi A, Rusmini P, et al. The role of the poly-glutamine tract in androgen receptor. J Steroid Biochem Mol Biol 2008; 108:245-253.
24. Ellerby LM, Hackam AS, Propp SS, et al. Kennedy's disease: caspase cleavage of the androgen receptor is a crucial event in cytotoxicity. J Neurochem 1999; 72:185-195.
25. Yang H, Murthy S, Sarkar FH, et al. Calpain-mediated andro-gen receptor breakdown in apoptotic prostate cancer cells. J Cell Physiol 2008; 217:569-576.
26. Libertini SJ, Tepper CG, Rodriguez V, et al. Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence. Cancer Res 2007; 67:9001-9005.
27. Shefin L, Keegan B, Zhang W, et al. Inhibiting proteasomes in human HepG2 and LNCaP cells increases endogenous an-drogen receptor levels. Biochem Biophys Res Commun 2000; 276:144-150.
28. Kobayashi Y, Kume A, Li M, et al. Chaperones Hsp70 and Hsp40 suppress aggregate formation and apoptosis in cultured neuronal cells expressing truncated androgen receptor protein with expanded polyglutamine tract. J Biol Chem 2000; 275:8772-8778.
29. Niu Y, Altuwaijri S, Lai KP, et al. Androgen receptor is a tumor suppressor and proliferator in prostate cancer. Proc Natl Acad Sci USA 2008; 105:12182-12187.
30. Bhuiyan MM, Li Y, Banerjee S, et al. Down-regulation of an-drogen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells. Cancer Res 2006; 66:10064-10072.
31. Tepper CG, Vinall RL, Wee CB, et al. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and-independent mechanisms. Prostate 2007; 67:521-535.
32. U M, Miyashita T, Ohtsuka Y, et al. Extended polyglutamine selectively interacts with caspase-8 and-10 in nuclear aggregates. Cell Death Differ 2001; 8:377-386.
33. Miyashita T, Matsui J, Ohtsuka Y, et al. Expression of extended polyglutamine sequentially activates initiator and effector caspases. Biochem Biophys Res Commun 1999; 257:724-730.
34. Xiang J, Gomez-Navarro J, Arafat W, et al. Pro-apoptotic treatment with an adenovirus encoding Bax enhances the effect of chemotherapy in ovarian cancer. J Gene Med 2000; 2:97-106.